VASO Financials 07/19/2014 14:31:47
Vasomedical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 May 31, 2010
Total Revenue 32,890 29,240 23,489 4,206
Cost of Revenue 10,377 8,646 6,733 1,994
Gross Profit 22,513 20,594 16,756 2,212
Operating Expenses
Research and Development 689 576 324 419
Sales, General and Admin. 23,114 23,526 11,243 3,773
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,290) (3,508) 5,189 (1,980)
Income From Continuing Operations
Add'l Income/Expense Items - 31 208 133
Earnings Before Interest and Tax (1,203) (3,329) 5,397 (1,847)
Interest Expense - - 9 5
Earnings Before Tax (1,203) (3,329) 5,388 (1,852)
Income Tax (58) 52 276 (36)
Minority Interest - - - 76
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,145) (3,381) 5,112 (1,892)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,145) (3,381) 5,112 (1,892)
Preferred Stock and Other Adjustments - - (1,221) -
Net Income Applicable to Common Shareholders (1,145) (3,381) 3,891 (1,892)
Vasomedical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 May 31, 2010
Total Revenue 32,890 29,240 23,489 4,206
Cost of Revenue 10,377 8,646 6,733 1,994
Gross Profit 22,513 20,594 16,756 2,212
Operating Expenses
Research and Development 689 576 324 419
Sales, General and Admin. 23,114 23,526 11,243 3,773
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,290) (3,508) 5,189 (1,980)
Income From Continuing Operations
Add'l Income/Expense Items - 31 208 133
Earnings Before Interest and Tax (1,203) (3,329) 5,397 (1,847)
Interest Expense - - 9 5
Earnings Before Tax (1,203) (3,329) 5,388 (1,852)
Income Tax (58) 52 276 (36)
Minority Interest - - - 76
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,145) (3,381) 5,112 (1,892)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,145) (3,381) 5,112 (1,892)
Preferred Stock and Other Adjustments - - (1,221) -
Net Income Applicable to Common Shareholders (1,145) (3,381) 3,891 (1,892)
